Showing 1 - 20 results of 395 for search '"Pharmaceutics"', query time: 0.07s Refine Results
  1. 1

    Nutraceuticals and Pharmaceuticals by E. A. Poluektova, A. G. Beniashvili, R. V. Maslennikov

    Published 2020-05-01
    “…The application of nutraceuticals, as well as their combined use with pharmaceuticals, in accordance with recommendations by scientific professional associations formulated on the basis of valid research studies can lead to an improvement in the quality of the life and longevity of the population. …”
    Get full text
    Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    EFFECT OF E-RECRUITMENT ON THE GROWTH OF PHARMACEUTICAL COMPANIES IN ILORIN, KWARA STATE by Nurudeen Bello Ahmed, Rabiat Omoshalewa Bashir

    Published 2023-11-01
    “…The study had a population of one hundred and sixty (160) managerial staff of the selected pharmaceutical firms in Kwara State. Data was analysed using descriptive and inferential statistics. …”
    Get full text
    Article
  7. 7

    Estimating Potential for Drug Budget Reallocation Following Expiration of Exclusivity of Pharmaceutical Products by Samira Toghanian, John Moshtaghi-Svensson, Maria Papageorgiou, Kristin Kittelsen, Christiaan Dolk, Markus Hultstrand, Stina Salomonsson

    Published 2022-02-01
    “…**Discussion:** These analyses showed that LOE for pharmaceutical products between 2020 and 2022 can result in significant increase in budget availability. …”
    Get full text
    Article
  8. 8

    Impact of a Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses by John E. Schneider, Anjani Parikh, Ivana Stojanovic

    Published 2018-02-01
    “…This study quantified the reduction in pharmaceutical expenses related to the use of an enhanced insulin management service to improve glycemic control. …”
    Get full text
    Article
  9. 9

    Contaminants in the Urban Environment: Pharmaceuticals and Personal Care Products (PPCPs)—Part 2 by Yun-Ya Yang, Gurpal S. Toor

    Published 2015-05-01
    “… Pharmaceuticals and personal care products contain a variety of chemical substances that enter household wastewater from bath and shower, sinks, and washers and ultimately find their way into the environment. …”
    Get full text
    Article
  10. 10

    FIRM’S CHARACTERISTICS AND EARNINGS MANAGEMENT: EVIDENCE FROM LISTED PHARMACEUTICAL COMPANIES IN NIGERIA by Muhammed BELLO, Leye Sherifdeen OYEDIRAN, Emmanuel Yinka ONIFADE

    Published 2023-12-01
    “…Thus, the purpose of this study is to examine how firm characteristics affect earnings management in the listed pharmaceutical sector of Nigeria. Using an ex-post facto study design, data was collected from yearly reports of specific pharmaceutical sectors in Nigeria from 2012 to 2021. …”
    Get full text
    Article
  11. 11

    Contaminants in the Urban Environment: Pharmaceuticals and Personal Care Products (PPCPs)—Part 1 by Yun-Ya Yang, Gurpal S. Toor

    Published 2015-05-01
    “… Pharmaceuticals and personal care products contain a variety of chemical substances that enter household wastewater from bath and shower, sinks, and washers and ultimately find their way into the environment. …”
    Get full text
    Article
  12. 12

    EFFECT OF WORKING CAPITAL MANAGEMENT ON FIRM’S VALUE: EVIDENCE FROM LISTED PHARMACEUTICAL FIRMS IN NIGERIA by Muhammed BELLO, Adeyemi KAMARDEEN, Shakirat Opeyemi SALAWUDEEN

    Published 2024-10-01
    “… Effective working capital management is crucial for the success and sustainability of listed pharmaceutical firms in Nigeria. The study examined the working capital management on firm’s value: evidence from listed pharmaceutical firms in Nigeria. …”
    Get full text
    Article
  13. 13

    The effect of R&D capitalization on revenue-expense matching: Focusing on the bio-pharmaceutical industries in South Korea by Dongjoon Choi, Inkyung Yoon, Hansol Lee

    Published 2025-02-01
    “…The study aims to investigate the effect of research and development (R&D) capitalization on revenue-expense matching in the pharmaceutical and biotechnology industries, with particular attention to the moderating role of corporate governance and the influence of regulatory intervention. …”
    Get full text
    Article
  14. 14
  15. 15
  16. 16

    EFFECT OF VALUE PROPOSITION AS A MARKETING STRATEGY ON INNOVATIVE CAPACITY OF THE PERFORMANCE OF PHARMACEUTICAL FIRMS IN KWARA STATE by Nurudeen Bello Ahmed, Aminu Nasir Brimah, Aremu Abdulganiyu Bello

    Published 2023-11-01
    “…The result of the study as (0.365,0.594 and 0.224) reveals that value proposition as a marketing strategy has significant effect on innovative capacity of pharmaceutical firms in Kwara State. Furthermore, the relationship between Value Proposition and Innovative Capacity as a marketing strategy impacts on the performance of pharmaceutical firms in Kwara State of Nigeria. …”
    Get full text
    Article
  17. 17

    The role of Pharmaceutical Marketing in Prescribing Decisions in a Developing Country: A Comprehensive Study Exploiting Theory of Planned Behaviour by Mahmoud Al-Areefi, Mohamed Izham Mohamed Ibrahim, Abubakr Abdelraouf Alfadl

    Published 2024-11-01
    “…Conclusion: This research clarified the role played by pharmaceutical companies to influence prescribing decisions of physicians. …”
    Get full text
    Article
  18. 18

    Recent progress in pharmaceutical excipients as P-glycoprotein inhibitors for potential improvement of oral drug bioavailability: A comprehensive overview by Fitrianti Darusman, Taofik Rusdiana, Iyan Sopyan, Hanifa Rahma, Millati Hanifa

    Published 2025-02-01
    “…Pharmaceutical excipients such as P-glycoprotein inhibitors can also increase the solubility and affinity of drugs to the intestinal membrane, enhance paracellular pathways and endocyte uptake, and activate lymph transport pathways, thereby increasing the bioavailability of oral drugs. …”
    Get full text
    Article
  19. 19
  20. 20

    The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation: A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need by Pierre-Alexandre Dionne, Farzad Ali, Mendel Grobler

    Published 2016-10-01
    “…New discoveries are a critical priority for the pharmaceutical industry. However, the use of fixed incremental cost-effectiveness (ICER) thresholds for health technology assessment (HTA) may compromise incentives to innovate and affect future treatment options. …”
    Get full text
    Article